Your Location:
Home >
Browse articles >
Repurposing a detrimental antibody epitope as targeted therapeutics for sepsis and rheumatoid arthritis
RESEARCH | Updated:2026-08-20
    • Repurposing a detrimental antibody epitope as targeted therapeutics for sepsis and rheumatoid arthritis

    • Wei-Qiang Chen , Li Lou , Xiao-Ling Qiang , Cassie Shu Zhu , Jian-Hua Li , Shu-Jin Chen , Brian Xiong , Huan Yang , Ping Wang , Kevin J. Tracey , Hai-Chao Wang
    • Military Medical Research Vol. 13, Issue 7, Pages: 1061-1080(2026)
    • DOI: 10.1186/s40779-026-00686-8     

      CLC:
    • Accepted:30 January 2026 ,

    Scan QR Code

  •  
  •  
  • Full Text(HTML)

  • Figs( 8 ) Tabs( 0 )

  • References

  • Publication Info

  • Metrics

Sections
icon
The trial reading is over, you can activate your VIP account to continue reading.
Deactivate >
icon
The trial reading is over. You can log in to your account, go to the personal center, purchase VIP membership, and read the full text.
Already a VIP member?
Log in >

35

Views

66

Downloads

0

CSCD

Alert me when the article has been cited
Submit
Tools
  • BibTeXDownload
  • EndnoteDownload
  • RefMan Download
  • NoteExpressDownload
  • NoteFirstDownload

Related Articles

An ongoing search for potential targets and therapies for lethal sepsis
Therapeutic effects of anti-endotoxin antibodies and antibiotics on endotoxemia in patients with severe burns
Metabolic syndrome and risk of sepsis and sepsis-related mortality: evidence from two large prospective cohort studies
Endothelial barrier and sepsis: mechanisms and potential therapeutic strategies
Maladaptive reorganization of mediodorsal thalamus as a central mechanism in neuropathic pain-related sleep disorders

Related Author

Guo-Qiang Bao
Li He
David Lee
John D’Angelo
Hai-Chao Wang
Shao-Yu Liu
Shao-Kang Xu
Jing-Li Gao

Related Institution

Department of Emergency Medicine, North Shore University Hospital
The Feinstein Institute for Medical Research, Community Drive
Department of General Surgery, Tangdu Hospital, The 4th Military Medical University
Department of Ophthalmology, University of Alabama at Birmingham
Department of Critical Care Medicine and Hematology, the Second Xiangya Hospital, Central South University